by Eric Wong
Gilead Sciences, a leading biopharmaceutical company and world leader in HIV/AIDS treatment, recently approached BTS with a unique opportunity. Gilead was challenged to expand its portfolio, retain top talent, and drive shareholder value. Most importantly, it needed to continue to develop and provide access to innovative therapies that address unmet medical needs. Gilead chose experiential learning as a powerful means to strategy execution.
Gilead partnered with BTS and another leading consulting firm to develop its first-ever senior leadership development program to help develop the capabilities of its most senior leaders. In a true partnership with Gilead, BTS designed a custom business simulation. Over the course of three days, participants were challenged to lead a company that closely resembled Gilead. The competitive simulation provided senior leaders with a common understanding of Gilead’s cross-functional business, including the knowledge and insights to produce results at the enterprise level.
This initiative has been running for almost two years and I continue to be impressed that a company with a deeply scientific culture was able to gain such value from a business simulation. It is both a humbling and a rewarding experience to partner with brilliant leaders to drive the leader alignment and mindset necessary to achieve their goals, especially when those goals are as noble as curing HIV/AIDS.
To read the full article, click here.